171 related articles for article (PubMed ID: 35492615)
1. Protective Effect of Purinergic P2X7 Receptor Inhibition on Acrolein-Induced Urothelial Cell Damage.
Taidi Z; Mansfield KJ; Sana-Ur-Rehman H; Moore KH; Liu L
Front Physiol; 2022; 13():885545. PubMed ID: 35492615
[TBL] [Abstract][Full Text] [Related]
2. P2X7 Receptor Blockade Protects Against Acrolein-Induced Bladder Damage: A Potential New Therapeutic Approach for the Treatment of Bladder Inflammatory Diseases.
Taidi Z; Zhou T; Moore KH; Mansfield KJ; Liu L
Front Pharmacol; 2021; 12():682520. PubMed ID: 34456718
[TBL] [Abstract][Full Text] [Related]
3. Blockade of Pannexin-1 Channels and Purinergic P2X7 Receptors Shows Protective Effects Against Cytokines-Induced Colitis of Human Colonic Mucosa.
Diezmos EF; Markus I; Perera DS; Gan S; Zhang L; Sandow SL; Bertrand PP; Liu L
Front Pharmacol; 2018; 9():865. PubMed ID: 30127744
[No Abstract] [Full Text] [Related]
4. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.
Mills KA; Chess-Williams R; McDermott C
Arch Toxicol; 2019 Nov; 93(11):3291-3303. PubMed ID: 31598736
[TBL] [Abstract][Full Text] [Related]
5. Localized inhibition of P2X7R at the spinal cord injury site improves neurogenic bladder dysfunction by decreasing urothelial P2X3R expression in rats.
Munoz A; Yazdi IK; Tang X; Rivera C; Taghipour N; Grossman RG; Boone TB; Tasciotti E
Life Sci; 2017 Feb; 171():60-67. PubMed ID: 28039004
[TBL] [Abstract][Full Text] [Related]
6. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
[TBL] [Abstract][Full Text] [Related]
7. Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice.
Huang CP; Chen CC; Tsai YT; Wu CC; Shyr CR
Cell Transplant; 2019 Mar; 28(3):296-305. PubMed ID: 30675801
[TBL] [Abstract][Full Text] [Related]
8. Improving the barrier function of damaged cultured urothelium using chondroitin sulfate.
Rozenberg BB; Janssen DAW; Jansen CFJ; Schalken JA; Heesakkers JPFA
Neurourol Urodyn; 2020 Feb; 39(2):558-564. PubMed ID: 31774209
[TBL] [Abstract][Full Text] [Related]
9. Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.
Zhang X; Gao S; Tanaka M; Zhang Z; Huang Y; Mitsui T; Kamiyama M; Koizumi S; Fan J; Takeda M; Yao J
J Cell Mol Med; 2017 Sep; 21(9):1791-1802. PubMed ID: 28244642
[TBL] [Abstract][Full Text] [Related]
10. Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor.
Platania CBM; Lazzara F; Fidilio A; Fresta CG; Conti F; Giurdanella G; Leggio GM; Salomone S; Drago F; Bucolo C
Biochem Pharmacol; 2019 Oct; 168():249-258. PubMed ID: 31302133
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
Antonioli L; Giron MC; Colucci R; Pellegrini C; Sacco D; Caputi V; Orso G; Tuccori M; Scarpignato C; Blandizzi C; Fornai M
PLoS One; 2014; 9(12):e116253. PubMed ID: 25549098
[TBL] [Abstract][Full Text] [Related]
12. Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells.
Nirmal J; Wolf-Johnston AS; Chancellor MB; Tyagi P; Anthony M; Kaufman J; Birder LA
Int Urol Nephrol; 2014 Oct; 46(10):1947-52. PubMed ID: 24875005
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of tight junction protein zonula occludens-2 and urothelium damage in a cyclophosphamide-induced mouse model of cystitis.
Chen YH; Chen CJ; Wang SJ; Lin YN; Chen WC; Tsai MY; Chen HY
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):399-406. PubMed ID: 29880173
[TBL] [Abstract][Full Text] [Related]
14. P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.
Freire D; Reyes RE; Baghram A; Davies DL; Asatryan L
J Neuroimmune Pharmacol; 2019 Jun; 14(2):263-277. PubMed ID: 30353422
[TBL] [Abstract][Full Text] [Related]
15. Changes in muscarinic receptors in the toad urothelial cell line TBM-54 following acrolein treatment.
Giglio D; Andersson M; Aronsson P; Delbro DS; Haraldsson B; Tobin G
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):217-22. PubMed ID: 17941892
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis.
Hader JE; Marzella L; Myers RA; Jacobs SC; Naslund MJ
J Urol; 1993 Jun; 149(6):1617-21. PubMed ID: 8501819
[TBL] [Abstract][Full Text] [Related]
18. Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H
Hiramoto S; Tsubota M; Yamaguchi K; Okazaki K; Sakaegi A; Toriyama Y; Tanaka J; Sekiguchi F; Ishikura H; Wake H; Nishibori M; Nguyen HD; Okada T; Toyooka N; Kawabata A
Cells; 2020 Jul; 9(8):. PubMed ID: 32707767
[TBL] [Abstract][Full Text] [Related]
19. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?
Collado-Díaz V; Martinez-Cuesta MÁ; Blanch-Ruiz MA; Sánchez-López A; García-Martínez P; Peris JE; Usach I; Ivorra MD; Lacetera A; Martín-Santamaría S; Esplugues JV; Alvarez A
Front Pharmacol; 2021; 12():613449. PubMed ID: 33867979
[TBL] [Abstract][Full Text] [Related]
20. Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption.
Wu X; Ren J; Chen G; Wu L; Song X; Li G; Deng Y; Wang G; Gu G; Li J
Sci Rep; 2017 Jun; 7(1):4364. PubMed ID: 28663567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
